Volume 12, Issue 4 (2-2025)
jmsthums 2025, 12(4): 67-78 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
SR N, GH A, F S, A M, SR K. Comparison of the effectiveness of brain stimulation therapy and metacognitive psychotherapy on the metacognitive beliefs of individuals with panic disorder. jmsthums 2025; 12 (4) :67-78
URL: http://jms.thums.ac.ir/article-1-1252-en.html
URL: http://jms.thums.ac.ir/article-1-1252-en.html
1- Department of Psychology, Birjand Branch, Islamic Azad University, Birjand, Iran
2- Department of Psychology, Neyshabur Branch, Islamic Azad University, Neyshabur, Iran
3- Department of Epidemiology and Biostatistics, School of Health, Torbat Heydariyeh University of Medical Sciences, Torbat Heydariyeh, Iran
2- Department of Psychology, Neyshabur Branch, Islamic Azad University, Neyshabur, Iran
3- Department of Epidemiology and Biostatistics, School of Health, Torbat Heydariyeh University of Medical Sciences, Torbat Heydariyeh, Iran
Abstract: (164 Views)
Background & Aim: Panic disorders are complex conditions that can be difficult to treat. Two methods that have shown promise in treating this disorder are brain stimulation, also known as transcranial direct current stimulation (tDCS), and metacognitive therapy. In order to determine the most effective approach, this study aimed to compare the impact of these two treatments on the metacognitive processes of individuals with panic disorder.
Methods: This study utilized a quasi-experimental pre-test-post-test design involving 45 individuals diagnosed with panic disorder. It was conducted in 2022 at the Mehr City Clinic in Mashhad. Participants were randomly assigned to three groups: two experimental groups consisting of 15 individuals each, one receiving tDCS and the other undergoing metacognitive therapy, along with a control group. The tDCS sessions were conducted individually and comprised of 16 sessions lasting 30 minutes each with a voltage of 2 milliamperes, while the metacognitive therapy sessions were conducted in groups over 10 sessions, each lasting 90 minutes. Metacognitive processes were assessed using Wells' Metacognitive Beliefs Questionnaire. Data analysis was performed using descriptive statistics and analysis of covariance with SPSS Version 24 software at a significance level of 5%.
Results: After the intervention, the mean and standard deviation of the scores for metacognitive processes were 73.81 ± 3.26 in the tDCS group, 64.33 ± 5.10 in the metacognitive therapy group, and 27.84 ± 3.26 in the control group. There was a statistically significant difference among the three groups (P = 0.001). The post-test phase showed a significant difference between the mean scores of metacognitive processes for participants in the experimental groups (−17.91) and the control group (−19.88) at a 95% confidence level (p < 0.05).
Conclusion: These findings suggest that metacognitive therapy has a more substantial effect on reducing metacognitive processes.
Methods: This study utilized a quasi-experimental pre-test-post-test design involving 45 individuals diagnosed with panic disorder. It was conducted in 2022 at the Mehr City Clinic in Mashhad. Participants were randomly assigned to three groups: two experimental groups consisting of 15 individuals each, one receiving tDCS and the other undergoing metacognitive therapy, along with a control group. The tDCS sessions were conducted individually and comprised of 16 sessions lasting 30 minutes each with a voltage of 2 milliamperes, while the metacognitive therapy sessions were conducted in groups over 10 sessions, each lasting 90 minutes. Metacognitive processes were assessed using Wells' Metacognitive Beliefs Questionnaire. Data analysis was performed using descriptive statistics and analysis of covariance with SPSS Version 24 software at a significance level of 5%.
Results: After the intervention, the mean and standard deviation of the scores for metacognitive processes were 73.81 ± 3.26 in the tDCS group, 64.33 ± 5.10 in the metacognitive therapy group, and 27.84 ± 3.26 in the control group. There was a statistically significant difference among the three groups (P = 0.001). The post-test phase showed a significant difference between the mean scores of metacognitive processes for participants in the experimental groups (−17.91) and the control group (−19.88) at a 95% confidence level (p < 0.05).
Conclusion: These findings suggest that metacognitive therapy has a more substantial effect on reducing metacognitive processes.
Type of Study: Research |
Subject:
Special
Received: 2024/01/24 | Accepted: 2024/04/23 | Published: 2025/03/15
Received: 2024/01/24 | Accepted: 2024/04/23 | Published: 2025/03/15
References
1. Ganji M. psychological pathology book DSM-5. 6th ed. Tehran: Savalan; 2019.
2. Borzoi T TM, Maghsoudi F, Assadi Hovyzian SH. Prevalence of Anxiety and Depression in Abadan Nursing Students During the COVID-19 Epidemic Preventive Medicine. 2022;9(1):0-.
3. Homayooni A HZ. Investigating the Relationship Between Perceived Stress and Health Anxiety and the Quality of Life (QoL) During the COVID-19 Pandemic. Preventive Medicine. 2022;9(1):38-49. [DOI:10.1186/s40359-023-01090-w]
4. Azad H. Psychopathology 1. Tehran: Besat; 1400.
5. Robert Joseph Boland MLV, Pedro Ruiz. Kaplan and Sadock's synopsis of psychiatry. 12th ed. Tehran: Arjmand; 2021.
6. Halgin RPW, Susan Cross. Psychopathology. 8th ed. Tehran: Ravan; 1400.
7. Moin al-Gharbai Fatemeh KS, Nofarsti Azam. Metacognitive components in people with generalized anxiety disorder, obsessive-compulsive disorder and depressive mood disorder. Iranian Journal of Psychiatry & Clinical Psychology. 2017;23(2). [DOI:10.29252/nirp.ijpcp.23.2.164]
8. Wells A. Metacognitive therapy for anxiety and depression: Guilford press; 2011.
9. Benjamin J. Sadock VAS, Pedro Ruiz. Kaplan and Sadock's Synopsis of Psychiatry: Behavioral Sciences/Clinical Psychiatry. Tehran: Arjmand; 2015.
10. Somaye Shafie-Sang-Atash PR, Mahmood Najafi The Efficacy of Metacognitive Therapy on Anxiety and Metacognitive Components in Individuals with Generalized Anxiety Disorder. Journal of Clinical Psychology. 2012;4(4):20-31.
11. Wells A. Metacognitive Therapy for Anxiety and Depression. Tehran: Ebn Sina; 2020.
12. Fredrikson J. Guideline of QEEG Applied and Neurotherapy. Tehran: Roshdefarhang; 2021.
13. Aparicio LV, Rosa V, Razza LM, Sampaio‐Junior B, Borrione L, Valiengo L, et al. Transcranial direct current stimulation (tDCS) for preventing major depressive disorder relapse: Results of a 6‐month follow‐up. Depression and anxiety. 2019;36(3):262-8. [DOI:10.1002/da.22878]
14. Noei Iran L, Rezaei A, Aghdasi AN. Comparison of the Effectiveness Metacognitive Therapy and Dialectical Behavioral Therapy on Students' Educational procrastination and Test Anxiety symptoms in Students. Knowledge & Research in Applied Psychology. 2021;84(22):59-70.
15. Pourebrahimi M, Rahimi C, Baniasadi R. The Effectiveness of Transcranial Direct Current Stimulation on the Pattern of Quantitative Electroencephalography and the Symptoms of Patients with Obsessive-Compulsive Disorder. Psychological Studies. 2021;17(3):33-52.
16. Bandelow B, Broocks A, Pekrun G, George A, Meyer T, Pralle L, et al. The use of the Panic and Agoraphobia Scale (P & A) in a controlled clinical trial. Pharmacopsychiatry. 2000;33(05):174-81. [DOI:10.1055/s-2000-12982]
17. Taghipur Dashblag B. Comparing the effectiveness of hypoventilation treatment and emotion regulation training on panic symptoms, anxiety sensitivity, worry and emotional processing of women with panic disorder: Faculty of Educational Sciences and Psychology, Mohaghegh Ardabili University; 2020.
18. faramarzi M-HBMJ-BMBKS. The Effectiveness of Meta-Cognitive Therapy on Meta-Cognitive Beliefs and Cognitive Trust in Patients with Social Phobia Disorder. Journal of Clinical Psychology. 2012;4(1):33-41.
19. Callesen P, Reeves D, Heal C, Wells A. Metacognitive therapy versus cognitive behaviour therapy in adults with major depression: a parallel single-blind randomised trial. Scientific reports. 2020;10(1):7878. [DOI:10.1038/s41598-020-64577-1]
Send email to the article author
| Rights and permissions | |
 | This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
This work is licensed under a Creative Commons Attribution 4.0 International License.
Designed & Developed by : Yektaweb